Research into new treatments and cures is vital to improving the lives of people with type 2 diabetes. You can directly contribute to important research and new breakthroughs by donating. Learn how to donate to organizations like the American Diabetes Association!
Get Involved with the
Caretalk's mission is to empower people to move progress forward in conditions like Type 2 Diabetes. An important way to get involved is in supporting research.
Why is research important?
Or, find a study near you >>
5 Ways to Get Involved
Great information about diabetes isn't so great if no one knows about it. Help other patients learn and take more control of their health by spreading the word! Share your experiences online, advocate for legislation, and share the importance of clinical research in making new treatments available for other patients.
There are exciting events in the diabetes community happening all the time. You can volunteer to help to make these events a success. Here are a few upcoming events !
Clinical trials are one of the cornerstones of medical innovation. Almost all of the treatments we rely on today were tested in trials, and there are tens of thousands of clinical trials testing the treatments of tomorrow, going on right now. However, about 50% of trials fail because they don't enroll enough patients. You can be a part of the next scientific breakthrough by participating. Learn if it's right for you by learning more about research on Caretalk!
Caretalk is a community of patients, caregivers, families, scientists, and clinicians who come together to share stories, knowledge, and support each other in their Type 2 Diabetes. When you join Caretalk, you not only get to learn, but you get the chance to participate in your health conversation. Learn more about Caretalk and sign up (it's free)!
A few studies that could be a good fit
Efficacy and Safety of Semaglutide 2.0 mg s.c. Once-weekly Compared to Semaglutide 1.0 mg s.c. Once-weekly in Subjects With Type 2 DiabetesLocated: | Houston, TX | Corvallis, OR Learn More
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Bexagliflozin in Subjects With Type 2 Diabetes Mellitus Who Are Not Adequately Controlled by Metformin AloneLocated: Chicago, IL | Chicago, IL | Chicago, IL Learn More
An Open-label, 2-Period, Fixed-sequence, Phase 1 Study in Healthy Volunteers to Evaluate the Effect of Itraconazole, a Potent CYP3A Inhibitor, on the Pharmacokinetics of IW-1973Located: Cambridge, MA | Cambridge, MA | Greer, SC Learn More
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Add-on Study of MLR 1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin TherapyLocated: Cambridge, MA | Hialeah, FL Learn More
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Dose Cohort Study to Evaluate the Efficacy and Safety of Twelve Once-weekly Subcutaneous Doses of PB-119 to Patients With Type 2 Diabetes Mellitus (T2DM) Not Well-controlled by Metformin MonotherapyLocated: Cambridge, MA | High Point, NC Learn More
Meet Some People Who Have
Participated In Research
I am a veteran with Type 2 Diabetes. Here is my story of advocacy through education & policy.
Taking a Healthier Lifestyle in Stride: My Journey with Type 2 Diabetes
Education, Community, and Family: My Story With Type 2 Diabetes
I was the primary Alzheimer's caregiver for my dear friend Mitzi. This is her & my family's story.
On Being a Caregiver For My Soulmate (Early-Onset Alzheimer's)
My Journey Caregiving for My Mom With Alzheimer's, and The Walk To End Alzheimer's